A citation-based method for searching scientific literature

Yang Pan, Peng Yang, Tao Dong, Yi Zhang, Weixian Shi, Xiaomin Peng, Shujuan Cui, Daitao Zhang, Guilan Lu, Yimeng Liu, Shuangsheng Wu, Quanyi Wang. Front Cell Infect Microbiol 2017
Times Cited: 19







List of co-cited articles
135 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


IFITM3 restricts the morbidity and mortality associated with influenza.
Aaron R Everitt, Simon Clare, Thomas Pertel, Sinu P John, Rachael S Wash, Sarah E Smith, Christopher R Chin, Eric M Feeley, Jennifer S Sims, David J Adams,[...]. Nature 2012
462
94

Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals.
Yong-Hong Zhang, Yan Zhao, Ning Li, Yan-Chun Peng, Eleni Giannoulatou, Rong-Hua Jin, Hui-Ping Yan, Hao Wu, Jin-Hua Liu, Ning Liu,[...]. Nat Commun 2013
165
78

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Abraham L Brass, I-Chueh Huang, Yair Benita, Sinu P John, Manoj N Krishnan, Eric M Feeley, Bethany J Ryan, Jessica L Weyer, Louise van der Weyden, Erol Fikrig,[...]. Cell 2009
814
63

Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection.
Zhongfang Wang, Anli Zhang, Yanmin Wan, Xinian Liu, Chao Qiu, Xiuhong Xi, Yanqin Ren, Jing Wang, Yuan Dong, Meijuan Bao,[...]. Proc Natl Acad Sci U S A 2014
183
63

IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.
Tanay M Desai, Mariana Marin, Christopher R Chin, George Savidis, Abraham L Brass, Gregory B Melikyan. PLoS Pathog 2014
164
57

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.
Eric M Feeley, Jennifer S Sims, Sinu P John, Christopher R Chin, Thomas Pertel, Li-Mei Chen, Gaurav D Gaiha, Bethany J Ryan, Ruben O Donis, Stephen J Elledge,[...]. PLoS Pathog 2011
241
52

Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection.
Adrienne G Randolph, Wai-Ki Yip, Emma Kaitlynn Allen, Carrie M Rosenberger, Anna A Agan, Stephanie A Ash, Yu Zhang, Tushar R Bhangale, David Finkelstein, Natalie Z Cvijanovich,[...]. J Infect Dis 2017
35
52

Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity.
Susana David, Vanessa Correia, Liliana Antunes, Ricardo Faria, José Ferrão, Paula Faustino, Baltazar Nunes, Fernando Maltez, João Lavinha, Helena Rebelo de Andrade. Immunogenetics 2018
13
69

SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.
E Kaitlynn Allen, Adrienne G Randolph, Tushar Bhangale, Pranay Dogra, Maikke Ohlson, Christine M Oshansky, Anthony E Zamora, John P Shannon, David Finkelstein, Amy Dressen,[...]. Nat Med 2017
83
47

IFITM proteins restrict viral membrane hemifusion.
Kun Li, Ruben M Markosyan, Yi-Min Zheng, Ottavia Golfetto, Brittani Bungart, Minghua Li, Shilei Ding, Yuxian He, Chen Liang, James C Lee,[...]. PLoS Pathog 2013
199
42


Ifitm3 limits the severity of acute influenza in mice.
Charles C Bailey, I-Chueh Huang, Christina Kam, Michael Farzan. PLoS Pathog 2012
149
42

The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization.
Rui Jia, Qinghua Pan, Shilei Ding, Liwei Rong, Shan-Lu Liu, Yunqi Geng, Wentao Qiao, Chen Liang. J Virol 2012
114
36

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.
I-Chueh Huang, Charles C Bailey, Jessica L Weyer, Sheli R Radoshitzky, Michelle M Becker, Jessica J Chiang, Abraham L Brass, Asim A Ahmed, Xiaoli Chi, Lian Dong,[...]. PLoS Pathog 2011
352
36

IFITM3 and severe influenza virus infection. No evidence of genetic association.
M López-Rodríguez, E Herrera-Ramos, J Solé-Violán, J J Ruíz-Hernández, L Borderías, J P Horcajada, E Lerma-Chippirraz, O Rajas, M Briones, M C Pérez-González,[...]. Eur J Clin Microbiol Infect Dis 2016
26
36


Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
Shokouh Makvandi-Nejad, Henry Laurenson-Schafer, LiLi Wang, Dannielle Wellington, Yan Zhao, Boquan Jin, Ling Qin, Kerry Kite, Hooman K Moghadam, Chaojun Song,[...]. J Infect Dis 2018
24
36

IFITM3, TLR3, and CD55 Gene SNPs and Cumulative Genetic Risks for Severe Outcomes in Chinese Patients With H7N9/H1N1pdm09 Influenza.
Nelson Lee, Bin Cao, Changwen Ke, Hongzhou Lu, Yunwen Hu, Claudia Ha Ting Tam, Ronald Ching Wan Ma, Dawei Guan, Zhaoqin Zhu, Hui Li,[...]. J Infect Dis 2017
28
36

IFITM3 and susceptibility to respiratory viral infections in the community.
Tara C Mills, Anna Rautanen, Katherine S Elliott, Tom Parks, Vivek Naranbhai, Margareta M Ieven, Christopher C Butler, Paul Little, Theo Verheij, Chris S Garrard,[...]. J Infect Dis 2014
54
36


IFITM-Family Proteins: The Cell's First Line of Antiviral Defense.
Charles C Bailey, Guocai Zhong, I-Chueh Huang, Michael Farzan. Annu Rev Virol 2014
203
31

The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.
Sinu P John, Christopher R Chin, Jill M Perreira, Eric M Feeley, Aaron M Aker, George Savidis, Sarah E Smith, Andrew E H Elia, Aaron R Everitt, Mehul Vora,[...]. J Virol 2013
105
31

IFITM3 rs12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysis.
Y Xuan, L N Wang, W Li, H R Zi, Y Guo, W J Yan, X B Chen, P M Wei. Epidemiol Infect 2015
24
31


Identification of an endocytic signal essential for the antiviral action of IFITM3.
Rui Jia, Fengwen Xu, Jin Qian, Yunfang Yao, Chunhui Miao, Yi-Min Zheng, Shan-Lu Liu, Fei Guo, Yunqi Geng, Wentao Qiao,[...]. Cell Microbiol 2014
76
31

The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.
Samad Amini-Bavil-Olyaee, Youn Jung Choi, Jun Han Lee, Mude Shi, I-Chueh Huang, Michael Farzan, Jae U Jung. Cell Host Microbe 2013
200
26

IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
Kevin Tartour, Romain Appourchaux, Julien Gaillard, Xuan-Nhi Nguyen, Stéphanie Durand, Jocelyn Turpin, Elodie Beaumont, Emmanuelle Roch, Gregory Berger, Renaud Mahieux,[...]. Retrovirology 2014
80
26

Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3.
Jacob S Yount, Bruno Moltedo, Yu-Ying Yang, Guillaume Charron, Thomas M Moran, Carolina B López, Howard C Hang. Nat Chem Biol 2010
238
26

Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity.
Alex A Compton, Nicolas Roy, Françoise Porrot, Anne Billet, Nicoletta Casartelli, Jacob S Yount, Chen Liang, Olivier Schwartz. EMBO Rep 2016
56
26

IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Alex A Compton, Timothée Bruel, Françoise Porrot, Adeline Mallet, Martin Sachse, Marine Euvrard, Chen Liang, Nicoletta Casartelli, Olivier Schwartz. Cell Host Microbe 2014
109
26

IFITM3 polymorphism rs12252-C restricts influenza A viruses.
David Evan Joseph Williams, Wan-Lin Wu, Christopher Robert Grotefend, Vladimir Radic, Changik Chung, Young-Hwa Chung, Michael Farzan, I-Chueh Huang. PLoS One 2014
33
26

Interferon-induced transmembrane protein-3 rs12252-C is associated with rapid progression of acute HIV-1 infection in Chinese MSM cohort.
Yonghong Zhang, Shokouh Makvandi-Nejad, Ling Qin, Yan Zhao, Tong Zhang, Lili Wang, Emmanouela Repapi, Stephen Taylor, Andrew McMichael, Ning Li,[...]. AIDS 2015
33
26

Human Genetic Determinants of Viral Diseases.
Adam D Kenney, James A Dowdle, Leonia Bozzacco, Temet M McMichael, Corine St Gelais, Amanda R Panfil, Yan Sun, Larry S Schlesinger, Matthew Z Anderson, Patrick L Green,[...]. Annu Rev Genet 2017
49
26


Hospitalization Risk Due to Respiratory Illness Associated with Genetic Variation at IFITM3 in Patients with Influenza A(H1N1)pdm09 Infection: A Case-Control Study.
Vânia Gaio, Baltazar Nunes, Pedro Pechirra, Patrícia Conde, Raquel Guiomar, Carlos Matias Dias, Marta Barreto. PLoS One 2016
12
41

The IFITMs Inhibit Zika Virus Replication.
George Savidis, Jill M Perreira, Jocelyn M Portmann, Paul Meraner, Zhiru Guo, Sharone Green, Abraham L Brass. Cell Rep 2016
126
26

IFITMs restrict the replication of multiple pathogenic viruses.
Jill M Perreira, Christopher R Chin, Eric M Feeley, Abraham L Brass. J Mol Biol 2013
133
26

IFITM3 directly engages and shuttles incoming virus particles to lysosomes.
Jennifer S Spence, Ruina He, Hans-Heinrich Hoffmann, Tandrila Das, Emmanuelle Thinon, Charles M Rice, Tao Peng, Kartik Chandran, Howard C Hang. Nat Chem Biol 2019
69
26

The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.
Yimeng Wang, Qinghua Pan, Shilei Ding, Zhen Wang, Jingyou Yu, Andrés Finzi, Shan-Lu Liu, Chen Liang. J Virol 2017
33
21

Evolutionary dynamics of the interferon-induced transmembrane gene family in vertebrates.
Zhao Zhang, Jun Liu, Meng Li, Hui Yang, Chiyu Zhang. PLoS One 2012
51
21

A diverse range of gene products are effectors of the type I interferon antiviral response.
John W Schoggins, Sam J Wilson, Maryline Panis, Mary Y Murphy, Christopher T Jones, Paul Bieniasz, Charles M Rice. Nature 2011
21


Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.
Kevin Tartour, Xuan-Nhi Nguyen, Romain Appourchaux, Sonia Assil, Véronique Barateau, Louis-Marie Bloyet, Julien Burlaud Gaillard, Marie-Pierre Confort, Beatriz Escudero-Perez, Henri Gruffat,[...]. PLoS Pathog 2017
30
21

The IFITM proteins inhibit HIV-1 infection.
Jennifer Lu, Qinghua Pan, Liwei Rong, Wei He, Shan-Lu Liu, Chen Liang. J Virol 2011
260
21

A membrane topology model for human interferon inducible transmembrane protein 1.
Stuart Weston, Stephanie Czieso, Ian J White, Sarah E Smith, Paul Kellam, Mark Marsh. PLoS One 2014
43
21

Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction.
Tsai-Yu Lin, Christopher R Chin, Aaron R Everitt, Simon Clare, Jill M Perreira, George Savidis, Aaron M Aker, Sinu P John, David Sarlah, Erick M Carreira,[...]. Cell Rep 2013
65
21

Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission.
Tonia C Carter, Scott J Hebbring, Jixia Liu, Jonathan D Mosley, Christian M Shaffer, Lynn C Ivacic, Sarah Kopitzke, Elisha L Stefanski, Rob Strenn, Maria E Sundaram,[...]. J Med Virol 2018
7
57

Identification of TMPRSS2 as a Susceptibility Gene for Severe 2009 Pandemic A(H1N1) Influenza and A(H7N9) Influenza.
Zhongshan Cheng, Jie Zhou, Kelvin Kai-Wang To, Hin Chu, Cun Li, Dong Wang, Dong Yang, Shufa Zheng, Ke Hao, Yohan Bossé,[...]. J Infect Dis 2015
90
21

pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
Thomas Gerlach, Luca Hensen, Tatyana Matrosovich, Janina Bergmann, Michael Winkler, Christin Peteranderl, Hans-Dieter Klenk, Friedemann Weber, Susanne Herold, Stefan Pöhlmann,[...]. J Virol 2017
39
21

Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications.
Nicholas M Chesarino, Temet M McMichael, Jacob S Yount. Future Microbiol 2014
41
21


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.